We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$216B
AUM Growth
+$23B
Cap. Flow
+$15.2B
Cap. Flow %
7.01%
Top 10 Hldgs %
16.18%
Holding
8,493
New
749
Increased
3,978
Reduced
2,659
Closed
707

Sector Composition

Rank Sector Weight
1 Financials 7.19%
2 Technology 6.4%
3 Healthcare 6.06%
4 Industrials 4.94%
5 Consumer Discretionary 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMUC
6576
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$16K ﹤0.01%
44,088
+43,963
+35,170% +$21.4K
EMSD
6577
DELISTED
WisdomTree Strong Dollar Emerging Markets Equity Fund
EMSD
$16K ﹤0.01%
575
+100
+21% +$2.84K
NMRX
6578
DELISTED
Numerex Corp
NMRX
$16K ﹤0.01%
+4,165
New +$17.3K
JJT
6579
DELISTED
iPath Bloomberg Tin Subindex Total Return ETN due June 24, 2038
JJT
$16K ﹤0.01%
329
-6
-2% -$278
MPACU
6580
DELISTED
Matlin & Partners Acquisition Corporation Units
MPACU
$16K ﹤0.01%
1,611
-923
-36% -$9.33K
BBDO icon
6581
Banco Bradesco
BBDO
$36.4B
$15K ﹤0.01%
2,266
-1,318
-37% -$8.19K
CAMT icon
6582
Camtek
CAMT
$6.18B
$15K ﹤0.01%
+3,000
New +$14.8K
CPIX icon
6583
Cumberland Pharmaceuticals
CPIX
$100M
$15K ﹤0.01%
2,071
-1,059
-34% -$7.32K
DALN
6584
DELISTED
DallasNews
DALN
$15K ﹤0.01%
823
+484
+143% +$9.6K
DIT icon
6585
AMCON Distributing
DIT
$61.1M
$15K ﹤0.01%
261
+151
+137% +$9.74K
EDN
6586
Edenor
EDN
$1.17B
$15K ﹤0.01%
376
-1,058
-74% -$35.4K
EQS icon
6587
Equus Total Return
EQS
$16.2M
$15K ﹤0.01%
+6,289
New +$14.7K
HIPS icon
6588
GraniteShares HIPS US High Income ETF
HIPS
$109M
$15K ﹤0.01%
841
+435
+107% +$7.83K
HUSV icon
6589
First Trust Horizon Managed Volatility Domestic ETF
HUSV
$75.9M
$15K ﹤0.01%
661
HWBK icon
6590
Hawthorn Bancshares
HWBK
$269M
$15K ﹤0.01%
944
-229
-20% -$3.7K
IDX icon
6591
VanEck Indonesia Index ETF
IDX
$32.1M
$15K ﹤0.01%
628
+378
+151% +$9.04K
IJR icon
6592
PUT
iShares Core S&P Small-Cap ETF
IJR
$110B
$15K ﹤0.01%
+200
New +$14K
IRIX icon
6593
IRIDEX
IRIX
$14.3M
$15K ﹤0.01%
1,650
-1,879
-53% -$17.1K
MERC icon
6594
Mercer International
MERC
$42.3M
$15K ﹤0.01%
1,232
-4,550
-79% -$51K
MVO
6595
DELISTED
MV Oil Trust
MVO
$15K ﹤0.01%
2,567
-1,378
-35% -$7.31K
NGS icon
6596
Natural Gas Services Group
NGS
$472M
$15K ﹤0.01%
537
-1,043
-66% -$25.8K
OVID icon
6597
Ovid Therapeutics
OVID
$414M
$15K ﹤0.01%
+1,770
New +$14.7K
RTC
6598
DELISTED
Baijiayun Group
RTC
$15K ﹤0.01%
1,183
+992
+519% +$13.6K
SCO icon
6599
ProShares UltraShort Bloomberg Crude Oil
SCO
$672M
$15K ﹤0.01%
6
-14
-70% -$43.8K
VO icon
6600
PUT
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$15K ﹤0.01%
+400
New +$14.4K

Similar funds

UBS Group's Q3 2017 Portfolio in Review

As of Q3 2017, UBS Group held 8,493 positions worth $216B, up 12% from $193B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $15.2B of net new capital in Q3 2017, opening 749 new positions and adding to 3,978 existing holdings. Its largest new stake was Baker Hughes: 613,477 shares worth $22.5M.

By sector, the portfolio is most concentrated in Financials at 7.2% of assets, down from 7.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Monsanto Co, an estimated $658M trimmed.

  • UBS Group's largest Q3 2017 buy was Baker Hughes: 613,477 shares worth $22.5M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $422M increase.
  • UBS Group's biggest Q3 2017 reduction was Monsanto Co, cutting an estimated $658M.
  • UBS Group fully exited Oneok Partners LP in Q3 2017, selling an estimated $218M.
  • UBS Group's ten largest holdings make up 16% of its $216B portfolio in Q3 2017.
  • UBS Group opened 749 new positions and closed 707 in Q3 2017.
  • UBS Group's portfolio value rose 12% quarter-over-quarter to $216B.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.